PMID: 6170971May 1, 1981Paper

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide

Postgraduate Medical Journal
M J VandenBurgF P Marsh

Abstract

Changes induced by i.v. and subcutaneous teprotide in plasma renin, angiotensin I, angiotensin II, aldosterone and bradykinin were studied in a renal transplant patient with severe high renin hypertension, before and after trinephrectomy. The immediate reduction in BP produced by teprotide was not solely attributable to the inhibition of conversion of angiotensin I to angiotensin II, because there was also a transient increase in serum bradykinin; however, the prolonged antihypertensive effect of teprotide appeared independent of bradykinin. After trinephrectomy, teprotide lowered systolic BP but had no significant effect on diastolic BP or plasma bradykinin. beta-Blockade prevented the secondary increase in plasma renin which followed teprotide, thereby potentiating its anti-hypertensive effect.

References

Jan 1, 1976·Annual Review of Biochemistry·R L Soffer
Jul 28, 1977·The New England Journal of Medicine·G H Williams, N K Hollenberg
Feb 1, 1975·Circulation Research·E G Erdös
Sep 23, 1978·British Medical Journal·M J VandenburgE J Rucinska
Jan 1, 1977·Circulation Research·M R Rosen, B F Hoffman
Feb 2, 1980·British Medical Journal·A J Man in 't VeldM A Schalekamp
Apr 19, 1980·British Medical Journal·B R LeslieE D Vaughan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.